Explore the Potential with AI-Driven Innovation
Our detailed focused library is generated on demand with advanced virtual screening and parameter assessment technology powered by the Receptor.AI drug discovery platform. This method surpasses traditional approaches, delivering compounds of better quality with enhanced activity, selectivity, and safety.
We pick out particular compounds from an extensive virtual database of more than 60 billion molecules. The preparation and shipment of these compounds are facilitated by our associate Reaxense.
The library features a range of promising modulators, each detailed with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Plus, each compound is presented with its ideal docking poses, affinity scores, and activity scores, ensuring a thorough insight.
Our high-tech, dedicated method is applied to construct targeted libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
It includes in-depth molecular simulations of both the catalytic and allosteric binding pockets, with ensemble virtual screening focusing on their conformational flexibility. For modulators, the process includes considering the structural shifts due to reaction intermediates to boost activity and selectivity.
Our library distinguishes itself through several key aspects:
partner
Reaxense
upacc
Q9BXT6
UPID:
M10L1_HUMAN
Alternative names:
Moloney leukemia virus 10-like protein 1
Alternative UPACC:
Q9BXT6; A7E211; A8MXC6; B7WPP1; B7Z7R1; F5H403; Q5TGD5; Q8NBD4; Q9NXW3; Q9UFB3; Q9UGX9
Background:
RNA helicase Mov10l1, also known as Moloney leukemia virus 10-like protein 1, plays a pivotal role in spermatogenesis. It represses transposable elements, preserving germline integrity through the piRNA metabolic process. This involves forming complexes with piRNAs and Piwi proteins, crucial for transposon methylation and repression. Mov10l1's ATP-dependent RNA helicase activity is essential, unwinding RNA to facilitate piRNA precursor processing.
Therapeutic significance:
Given its critical function in spermatogenesis, Mov10l1's association with Spermatogenic failure 73, a male infertility disorder due to meiotic arrest, underscores its therapeutic potential. Understanding Mov10l1's role could unveil novel strategies for treating infertility.